Upload
Featured Recent Articles Topics Login Upload

Search Results for 'aspirin study'

aspirin study published presentations and documents on DocSlides.

Aspirin in Cardioprevention:
Aspirin in Cardioprevention:
by pamella-moone
The Role of Aspirin Today. Our Good Old Friend As...
THE PREVALENCE AND ASSOCIAED FACORS OF IC ASPIRIN
THE PREVALENCE AND ASSOCIAED FACORS OF IC ASPIRIN
by harmony
50 Corresponding author: L RTICLERef: Ro J Neurol....
Aspirin resistance among patients with recurrent
Aspirin resistance among patients with recurrent
by genevieve
89 non-cardioembolic stroke detected by rapid plat...
Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
by danika-pritchard
Original Article Low-Dose Aspirin for Preventin...
Statistics and Experimentation
Statistics and Experimentation
by alida-meadow
David . Salsburg. AP Statistics Reading. Daytona ...
One Size May Not Fit All:
One Size May Not Fit All:
by olivia-moreira
A New Aspirin Option for the High-Risk Patient . ...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
Pharmacodynamic Profile of PL-ASA, a Novel Phospholipid-Aspirin Complex Liquid Formulation, Compare
Pharmacodynamic Profile of PL-ASA, a Novel Phospholipid-Aspirin Complex Liquid Formulation, Compare
by hanah
Franchi F, Schneider DJ, Prats J, Fan W, . Rollini...
REATMENT ALGORITHMS
REATMENT ALGORITHMS
by melody
People with diabetes have a 2 to 4 fold higher ris...
x0000x0000 xAttxachex
x0000x0000 xAttxachex
by ani
�� ��NDA 20-839...
Dual Anti-Platelet Therapy After TAVR?
Dual Anti-Platelet Therapy After TAVR?
by salem
By: Cole Smith PharmD Candidate 2021. University o...
Switching from dual antiplatelet therapy with aspirin plus a P2Y
Switching from dual antiplatelet therapy with aspirin plus a P2Y
by brown
12. inhibitor to dual pathway inhibition with asp...
The Canadian Journal of CME June 2003
The Canadian Journal of CME June 2003
by evans
atrophiclichen sclerosusWhat is the difference bet...
UOG Journal Club: October 2017
UOG Journal Club: October 2017
by leah
ASPRE trial: performance . of screening for preter...
NYU WOMEN146S HEALTH STUDY FOLLOWUP QUESTIONNAIRE
NYU WOMEN146S HEALTH STUDY FOLLOWUP QUESTIONNAIRE
by hailey
1Below are your name address and telephone number ...
Judicious Use of Anticoagulation: A Case-Based Approach
Judicious Use of Anticoagulation: A Case-Based Approach
by sherrill-nordquist
Judicious Use of Anticoagulation: A Case-Based Ap...
A New Era for NOACs: Program Goals
A New Era for NOACs: Program Goals
by danika-pritchard
Evidence For NOACs in Patients With NVAF-PCI. PIO...